Evidence map›Paper›PMID 26403934›Full record

ArticleStatistical methods in medical research2017

An ensemble survival model for estimating relative residual longevity following stroke: Application to mortality data in the chronic dialysis population.

Milind A Phadnis, James B Wetmore, Theresa I Shireman, Edward F Ellerbeck, Jonathan D Mahnken

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Milind A Phadnis1 Departments of Biostatistics, University of Kansas School of Medicine, Kansas City, KS, USA.
James B Wetmore2 Division of Nephrology, Hennepin County Medical Center, Minneapolis, MN, USA.
Theresa I Shireman4 Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, KS, USA.
Edward F Ellerbeck4 Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, KS, USA.
Jonathan D Mahnken1 Departments of Biostatistics, University of Kansas School of Medicine, Kansas City, KS, USA.

Funding

Are Cardioprotective Medications Effective in ESRD?R01DK080111 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SHIREMAN, THERESA I. · 2008 to 2011
$1.4M
Factors Associated with Warfarin Use in Dialysis Patients w/ Atrial FibrillationK23DK085378 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WETMORE, JAMES BACON · 2010 to 2014
$861k
NIDDK NIH HHS K23 DK085378NIDDK NIH HHS R01 DK080111
6 · The paper itself

Abstract

Time-dependent covariates can be modeled within the Cox regression framework and can allow both proportional and nonproportional hazards for the risk factor of research interest. However, in many areas of health services research, interest centers on being able to estimate residual longevity after the occurrence of a particular event such as stroke. The survival trajectory of patients experiencing a stroke can be potentially influenced by stroke type (hemorrhagic or ischemic), time of the stroke (relative to time zero), time since the stroke occurred, or a combination of these factors. In such situations, researchers are more interested in estimating lifetime lost due to stroke rather than merely estimating the relative hazard due to stroke. To achieve this, we propose an ensemble approach using the generalized gamma distribution by means of a semi-Markov type model with an additive hazards extension. Our modeling framework allows stroke as a time-dependent covariate to affect all three parameters (location, scale, and shape) of the generalized gamma distribution. Using the concept of relative times, we answer the research question by estimating residual life lost due to ischemic and hemorrhagic stroke in the chronic dialysis population.

Indexed as

Models, StatisticalSurvival AnalysisBiostatisticsHumansLongevityMarkov ChainsProportional Hazards ModelsRenal DialysisRisk FactorsStrokeAdditive hazardsgeneralized gammarelative timesresidual median lifesemi-Markov model

Identifiers

PMID26403934
PMCPMC5311029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.